{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:13:17Z","timestamp":1788520397195,"version":"build-2803163510"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11356-022-18534-2","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T02:02:52Z","timestamp":1642212172000},"page":"18408-18422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus"],"prefix":"10.1007","volume":"29","author":[{"given":"Nasr E.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadry M.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"18534_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diabres.2018.03.042","volume":"140","author":"TK Abouzed","year":"2018","unstructured":"Abouzed TK, Contreras MDM, Sadek KM, Shukry M, D HA, Gouda WM, Abdo W, Nasr NE, Mekky RH, Segura-Carretero A, Kahilo KA, Abdel-Sattar E, (2018) Red onion scales ameliorated streptozotocin-induced diabetes and diabetic nephropathy in Wistar rats in relation to their metabolite fingerprint. Diabetes Res Clin Pract 140:253\u2013264","journal-title":"Diabetes Res Clin Pract"},{"key":"18534_CR2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1110\/ps.03460604","volume":"13","author":"K Aertgeerts","year":"2004","unstructured":"Aertgeerts K, Ye S, Tennant MG, Kraus ML, Rogers J, Sang BC, Skene RJ, Webb DR, Prasad GS (2004) Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. Protein Sci 13:412\u2013421","journal-title":"Protein Sci"},{"key":"18534_CR3","doi-asserted-by":"crossref","first-page":"40525","DOI":"10.1007\/s11356-020-09997-2","volume":"27","author":"G Albasher","year":"2020","unstructured":"Albasher G, Alwahaibi M, Abdel-Daim MM, Alkahtani S, Almeer R (2020) Protective effects of Artemisia judaica extract compared to metformin against hepatorenal injury in high-fat diet\/streptozotocine-induced diabetic rats. Environ Sci Pollut Res 27:40525\u201340536","journal-title":"Environ Sci Pollut Res"},{"key":"18534_CR4","doi-asserted-by":"crossref","unstructured":"Aleissa MS, Alkahtani S, Abd Eldaim MA, Ahmed AM, Bung\u0103u SG, Almutairi B, Bin-Jumah M, AlKahtane AA, Alyousif MS, Abdel-Daim MM (2020): Fucoidan ameliorates oxidative stress, inflammation, DNA damage, and hepatorenal injuries in diabetic rats intoxicated with aflatoxin B1. Oxidative medicine and cellular longevity 2020","DOI":"10.1155\/2020\/9316751"},{"key":"18534_CR5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/01.RES.83.11.1132","volume":"83","author":"AP Babenko","year":"1998","unstructured":"Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J (1998) Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res 83:1132\u20131143","journal-title":"Circ Res"},{"key":"18534_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.onc.1203292","volume":"19","author":"B Bauvois","year":"2000","unstructured":"Bauvois B, Djavaheri-Mergny M, Rouillard D, Dumont J, Wietzerbin J (2000) Regulation of CD26\/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 19:265\u2013272","journal-title":"Oncogene"},{"key":"18534_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.1902.sp000920","volume":"28","author":"WM Bayliss","year":"1902","unstructured":"Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28:325\u2013353","journal-title":"J Physiol"},{"issue":"Pt 3","key":"18534_CR8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3110835","volume":"311","author":"SK Bohm","year":"1995","unstructured":"Bohm SK, Gum JR Jr, Erickson RH, Hicks JW, Kim YS (1995) Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J 311(Pt 3):835\u2013843","journal-title":"Biochem J"},{"key":"18534_CR9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0025-7125(16)32076-4","volume":"58","author":"JC Brown","year":"1974","unstructured":"Brown JC (1974) \u201cEnterogastrone\u201d and other new gut peptides. Med Clin North Am 58:1347\u20131358","journal-title":"Med Clin North Am"},{"key":"18534_CR10","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1172\/JCI200320501","volume":"112","author":"M Brownlee","year":"2003","unstructured":"Brownlee M (2003) A radical explanation for glucose-induced beta cell dysfunction. J Clin Investig 112:1788\u20131790","journal-title":"J Clin Investig"},{"key":"18534_CR11","first-page":"989","volume":"7","author":"A Capuano","year":"2013","unstructured":"Capuano A, Sportiello L, Maiorino MI, Rossi F, Giugliano D, Esposito K (2013) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy\u2014focus on alogliptin. Drug Des Dev Ther 7:989\u20131001","journal-title":"Drug Des Dev Ther"},{"key":"18534_CR12","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.90233.2008","volume":"295","author":"RD Carr","year":"2008","unstructured":"Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahr\u00e9n B (2008) Incretin and islet hormonal responses to fat and protein ingestion in healthy men. American Journal of Physiology-Endocrinology and Metabolism 295:E779\u2013E784","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"18534_CR13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/1440-1681.12455","volume":"42","author":"XW Chen","year":"2015","unstructured":"Chen XW, He ZX, Zhou ZW, Yang T, Zhang X, Yang YX, Duan W, Zhou SF (2015) Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol 42:999\u20131024","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"18534_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jdi.12305","volume":"6","author":"YM Cho","year":"2015","unstructured":"Cho YM (2015) Incretin physiology and pathophysiology from an Asian perspective. Journal of Diabetes Investigation 6:495\u2013507","journal-title":"Journal of Diabetes Investigation"},{"key":"18534_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3904\/kjim.2010.25.2.119","volume":"25","author":"K Choi","year":"2010","unstructured":"Choi K, Kim Y-B (2010) Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 25:119","journal-title":"Korean J Intern Med"},{"key":"18534_CR16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0171-2985(97)80084-8","volume":"197","author":"OJ Cordero","year":"1997","unstructured":"Cordero OJ, Salgado FJ, Vinuela JE, Nogueira M (1997) Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes. Immunobiology 197:522\u2013533","journal-title":"Immunobiology"},{"key":"18534_CR17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00262-009-0728-1","volume":"58","author":"OJ Cordero","year":"2009","unstructured":"Cordero OJ, Salgado FJ, Nogueira M (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunology, Immunotherapy\u202f: CII 58:1723\u20131747","journal-title":"Cancer Immunology, Immunotherapy : CII"},{"key":"18534_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","volume":"16","author":"W Creutzfeldt","year":"1979","unstructured":"Creutzfeldt W (1979) The incretin concept today. Diabetologia 16:75\u201385","journal-title":"Diabetologia"},{"key":"18534_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1463-1326.2010.01306.x","volume":"13","author":"CF Deacon","year":"2011","unstructured":"Deacon CF (2011) Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review. Diabetes Obes Metab 13:7\u201318","journal-title":"Diabetes Obes Metab"},{"key":"18534_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fendo.2019.00080","volume":"10","author":"CF Deacon","year":"2019","unstructured":"Deacon CF (2019) Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol 10:80","journal-title":"Front Endocrinol"},{"key":"18534_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773\u2013795","journal-title":"Diabetes"},{"key":"18534_CR22","first-page":"E410","volume":"300","author":"AD Dobrian","year":"2011","unstructured":"Dobrian AD, Ma Q, Lindsay JW, Leone KA, Ma K, Coben J, Galkina EV, Nadler JL (2011) Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. American journal of physiology. Endocrinol Metab 300:E410\u2013E421","journal-title":"Endocrinol Metab"},{"key":"18534_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165","journal-title":"Cell Metab"},{"key":"18534_CR24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696\u20131705","journal-title":"Lancet"},{"key":"18534_CR25","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","volume":"84","author":"DJ Drucker","year":"1987","unstructured":"Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987) Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84:3434\u20133438","journal-title":"Proc Natl Acad Sci USA"},{"key":"18534_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/diab.15.8.555","volume":"15","author":"J Dupre","year":"1966","unstructured":"Dupre J, Beck JC (1966) Stimulation of release of insulin by an extract of intestinal mucosa. Diabetes 15:555\u2013559","journal-title":"Diabetes"},{"key":"18534_CR27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1210\/endo-111-5-1601","volume":"111","author":"R Ebert","year":"1982","unstructured":"Ebert R, Creutzfeldt W (1982) Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats. Endocrinology 111:1601\u20131606","journal-title":"Endocrinology"},{"key":"18534_CR28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00257346","volume":"24","author":"R Ebert","year":"1983","unstructured":"Ebert R, Unger H, Creutzfeldt W (1983) Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 24:449\u2013454","journal-title":"Diabetologia"},{"key":"18534_CR29","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1073\/pnas.0230620100","volume":"100","author":"M Engel","year":"2003","unstructured":"Engel M, Hoffmann T, Wagner L, Wermann M, Heiser U, Kiefersauer R, Huber R, Bode W, Demuth HU, Brandstetter H (2003) The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc Natl Acad Sci USA 100:5063\u20135068","journal-title":"Proc Natl Acad Sci USA"},{"key":"18534_CR30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jmb.2005.11.014","volume":"355","author":"M Engel","year":"2006","unstructured":"Engel M, Hoffmann T, Manhart S, Heiser U, Chambre S, Huber R, Demuth HU, Bode W (2006) Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV. J Mol Biol 355:768\u2013783","journal-title":"J Mol Biol"},{"key":"18534_CR31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/en.2012-1855","volume":"154","author":"N Ervinna","year":"2013","unstructured":"Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S, Sukmawati D, Nomiyama T, Kanazawa A, Kawamori R, Fujitani Y, Watada H (2013) Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology 154:1260\u20131270","journal-title":"Endocrinology"},{"key":"18534_CR32","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1210\/en.2003-0323","volume":"144","author":"L Farilla","year":"2003","unstructured":"Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149\u20135158","journal-title":"Endocrinology"},{"key":"18534_CR33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/13813455.2018.1499119","volume":"126","author":"MS Fawzy","year":"2020","unstructured":"Fawzy MS, Abu AlSel BT, Al Ageeli E, Al-Qahtani SA, Abdel-Daim MM, Toraih EA (2020) Long non-coding RNA MALAT1 and microRNA-499a expression profiles in diabetic ESRD patients undergoing dialysis: a preliminary cross-sectional analysis. Arch Physiol Biochem 126:172\u2013182","journal-title":"Arch Physiol Biochem"},{"key":"18534_CR34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-5793(91)80182-3","volume":"279","author":"HC Fehmann","year":"1991","unstructured":"Fehmann HC, Habener JF (1991) Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7\u201337) on a somatostatin secreting cell line. FEBS Lett 279:335\u2013340","journal-title":"FEBS Lett"},{"key":"18534_CR35","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","volume":"63","author":"R Fredriksson","year":"2003","unstructured":"Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256\u20131272","journal-title":"Mol Pharmacol"},{"key":"18534_CR36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/00498254.2012.731618","volume":"43","author":"S Furuta","year":"2013","unstructured":"Furuta S, Smart C, Hackett A, Benning R, Warrington S (2013) Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 43:432\u2013442","journal-title":"Xenobiotica; the Fate of Foreign Compounds in Biological Systems"},{"key":"18534_CR37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.biopha.2018.08.013","volume":"107","author":"M Gadelkarim","year":"2018","unstructured":"Gadelkarim M, Abushouk AI, Ghanem E, Hamaad AM, Saad AM, Abdel-Daim MM (2018) Adipose-derived stem cells: effectiveness and advances in delivery in diabetic wound healing. Biomed Pharmacother 107:625\u2013633","journal-title":"Biomed Pharmacother"},{"key":"18534_CR38","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S1262-3636(08)73397-4","volume":"34","author":"J-F Gautier","year":"2008","unstructured":"Gautier J-F, Choukem S-P, Girard J (2008) Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab 34:S65\u2013S72","journal-title":"Diabetes Metab"},{"key":"18534_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40265-017-0706-4","volume":"77","author":"B Geloneze","year":"2017","unstructured":"Geloneze B, de Lima-Junior JC, Velloso LA (2017) Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the brain-adipocyte axis. Drugs 77:493\u2013503","journal-title":"Drugs"},{"key":"18534_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1160357","volume":"116","author":"R Goke","year":"1988","unstructured":"Goke R, Conlon JM (1988) Receptors for glucagon-like peptide-1(7\u201336) amide on rat insulinoma-derived cells. J Endocrinol 116:357\u2013362","journal-title":"J Endocrinol"},{"key":"18534_CR41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/diabetes.52.5.1147","volume":"52","author":"FM Gribble","year":"2003","unstructured":"Gribble FM, Williams L, Simpson AK, Reimann F (2003) A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52:1147\u20131154","journal-title":"Diabetes"},{"key":"18534_CR42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-5793(98)00254-3","volume":"425","author":"J Gromada","year":"1998","unstructured":"Gromada J, Anker C, Bokvist K, Knudsen LB, Wahl P (1998) Glucagon-like peptide-1 receptor expression in Xenopus oocytes stimulates inositol trisphosphate-dependent intracellular Ca2+ mobilization. FEBS Lett 425:277\u2013280","journal-title":"FEBS Lett"},{"key":"18534_CR43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1440-1681.2008.05015.x","volume":"35","author":"N Gu","year":"2008","unstructured":"Gu N, Tsuda M, Matsunaga T, Adachi T, Yasuda K, Ishihara A, Tsuda K (2008) Glucose regulation of dipeptidyl peptidase IV gene expression is mediated by hepatocyte nuclear factor-1alpha in epithelial intestinal cells. Clin Exp Pharmacol Physiol 35:1433\u20131439","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"18534_CR44","doi-asserted-by":"crossref","first-page":"12348","DOI":"10.1038\/srep12348","volume":"5","author":"R Han","year":"2015","unstructured":"Han R, Wang X, Bachovchin W, Zukowska Z, Osborn JW (2015) Inhibition of dipeptidyl peptidase 8\/9 impairs preadipocyte differentiation. Sci Rep 5:12348","journal-title":"Sci Rep"},{"key":"18534_CR45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diab.46.5.785","volume":"46","author":"RS Heller","year":"1997","unstructured":"Heller RS, Kieffer TJ, Habener JF (1997) Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 46:785\u2013791","journal-title":"Diabetes"},{"key":"18534_CR46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","volume":"11","author":"A Hirasawa","year":"2005","unstructured":"Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90\u201394","journal-title":"Nat Med"},{"key":"18534_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-5793(93)81609-4","volume":"336","author":"T Hoffmann","year":"1993","unstructured":"Hoffmann T, Faust J, Neubert K, Ansorge S (1993) Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS Lett 336:61\u201364","journal-title":"FEBS Lett"},{"key":"18534_CR48","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/diacare.26.3.917","volume":"26","author":"P Hogan","year":"2003","unstructured":"Hogan P, Dall T, Nikolov P, American Diabetes A (2003) Economic costs of diabetes in the US in 2002. Diabetes Care 26:917\u2013932","journal-title":"Diabetes Care"},{"key":"18534_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","volume":"297","author":"JJ Holst","year":"2009","unstructured":"Holst JJ, Vilsboll T, Deacon CF (2009) The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297:127\u2013136","journal-title":"Mol Cell Endocrinol"},{"key":"18534_CR50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-5793(84)81245-4","volume":"178","author":"NM Hoosein","year":"1984","unstructured":"Hoosein NM, Gurd RS (1984) Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett 178:83\u201386","journal-title":"FEBS Lett"},{"key":"18534_CR51","first-page":"197","volume":"7","author":"VK Hopsu-Havu","year":"1966","unstructured":"Hopsu-Havu VK, Glenner GG (1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie Histochemistry Histochimie 7:197\u2013201","journal-title":"Histochemie Histochemistry Histochimie"},{"key":"18534_CR52","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1210\/jc.2014-3978","volume":"100","author":"L Kelstrup","year":"2015","unstructured":"Kelstrup L, Clausen TD, Mathiesen ER, Hansen T, Holst JJ, Damm P (2015) Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy. J Clin Endocrinol Metab 100:1967\u20131975","journal-title":"J Clin Endocrinol Metab"},{"key":"18534_CR53","doi-asserted-by":"crossref","unstructured":"Kim NH, Yu T, Lee DH (2014): The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. BioMed research international 2014, 368703","DOI":"10.1155\/2014\/368703"},{"key":"18534_CR54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/CS20090047","volume":"118","author":"M Kirby","year":"2010","unstructured":"Kirby M, Yu DM, O\u2019connor S, Gorrell MD (2010) Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Clin Sci 118:31\u201341","journal-title":"Clin Sci"},{"key":"18534_CR55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2004.05.002","volume":"103","author":"K Kristiansen","year":"2004","unstructured":"Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21\u201380","journal-title":"Pharmacol Ther"},{"key":"18534_CR56","doi-asserted-by":"crossref","first-page":"29839","DOI":"10.1074\/jbc.M103106200","volume":"276","author":"AM Lambeir","year":"2001","unstructured":"Lambeir AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, Scharpe S, Van Damme J, De Meester I (2001) Kinetic investigation of chemokine truncation by CD26\/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 276:29839\u201329845","journal-title":"J Biol Chem"},{"key":"18534_CR57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","volume":"40","author":"AM Lambeir","year":"2003","unstructured":"Lambeir AM, Durinx C, Scharpe S, De Meester I (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40:209\u2013294","journal-title":"Crit Rev Clin Lab Sci"},{"key":"18534_CR58","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","volume":"60","author":"D Lamers","year":"2011","unstructured":"Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60:1917\u20131925","journal-title":"Diabetes"},{"key":"18534_CR59","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365528009181538","volume":"15","author":"KB Lauritsen","year":"1980","unstructured":"Lauritsen KB, Moody AJ, Christensen KC, Lindkaer Jensen S (1980) Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man. Scand J Gastroenterol 15:833\u2013840","journal-title":"Scand J Gastroenterol"},{"key":"18534_CR60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11892-008-0031-0","volume":"8","author":"C Lencioni","year":"2008","unstructured":"Lencioni C, Lupi R, Del Prato S (2008) Beta-cell failure in type 2 diabetes mellitus. Curr DiabRep 8:179\u2013184","journal-title":"Curr DiabRep"},{"key":"18534_CR61","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2014-3865","volume":"100","author":"O Lindgren","year":"2015","unstructured":"Lindgren O, Pacini G, Tura A, Holst JJ, Deacon CF, Ahr\u00e9n B (2015) Incretin effect after oral amino acid ingestion in humans. J Clin Endocrinol Metab 100:1172\u20131176","journal-title":"J Clin Endocrinol Metab"},{"key":"18534_CR62","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1021\/bi060184f","volume":"45","author":"KL Longenecker","year":"2006","unstructured":"Longenecker KL, Stewart KD, Madar DJ, Jakob CG, Fry EH, Wilk S, Lin CW, Ballaron SJ, Stashko MA, Lubben TH, Yong H, Pireh D, Pei Z, Basha F, Wiedeman PE, von Geldern TW, Trevillyan JM, Stoll VS (2006) Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors. Biochemistry 45:7474\u20137482","journal-title":"Biochemistry"},{"key":"18534_CR63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/DMSO.S61438","volume":"7","author":"D Lorber","year":"2014","unstructured":"Lorber D (2014) Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity\u202f: Targets and Therapy 7:169\u2013183","journal-title":"Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy"},{"key":"18534_CR64","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","volume":"97","author":"A Makdissi","year":"2012","unstructured":"Makdissi A, Ghanim H, Vora M, Green K, Abuaysheh S, Chaudhuri A, Dhindsa S, Dandona P (2012) Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab 97:3333\u20133341","journal-title":"J Clin Endocrinol Metab"},{"key":"18534_CR65","doi-asserted-by":"crossref","unstructured":"Mamdouh M, Shaban S, Ibrahim Abushouk A, Zaki MMM, Ahmed OM, Abdel-Daim MM (2017): Adipokines: potential therapeutic targets for vascular dysfunction in type II diabetes mellitus and obesity. Journal of Diabetes Research 2017","DOI":"10.1155\/2017\/8095926"},{"key":"18534_CR66","doi-asserted-by":"crossref","unstructured":"Marks V (2017): Temporary removal: rebirth of the incretin concept: its conception and early development. Peptides","DOI":"10.1016\/j.peptides.2017.08.002"},{"issue":"Suppl 3","key":"18534_CR67","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.2337\/diabetes.51.2007.S394","volume":"51","author":"FM Matschinsky","year":"2002","unstructured":"Matschinsky FM (2002) Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 51(Suppl 3):S394-404","journal-title":"Diabetes"},{"key":"18534_CR68","first-page":"595","volume":"84","author":"T Mattern","year":"1995","unstructured":"Mattern T, Reich C, Duchrow M, Ansorge S, Ulmer AJ, Flad HD (1995) Antibody-induced modulation of CD26 surface expression. Immunology 84:595\u2013600","journal-title":"Immunology"},{"key":"18534_CR69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dmrr.538","volume":"21","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Nauck MA (2005) Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes Metab Res Rev 21:91\u2013117","journal-title":"Diabetes Metab Res Rev"},{"key":"18534_CR70","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1110\/ps.073253208","volume":"17","author":"WJ Metzler","year":"2008","unstructured":"Metzler WJ, Yanchunas J, Weigelt C, Kish K, Klei HE, Xie D, Zhang Y, Corbett M, Tamura JK, He B, Hamann LG, Kirby MS, Marcinkeviciene J (2008) Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation. Protein Sci 17:240\u2013250","journal-title":"Protein Sci"},{"key":"18534_CR71","first-page":"E1049","volume":"287","author":"C Meyer","year":"2004","unstructured":"Meyer C, Woerle HJ, Dostou JM, Welle SL, Gerich JE (2004) Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes. American journal of physiology. Endocrinol Metab 287:E1049\u2013E1056","journal-title":"Endocrinol Metab"},{"key":"18534_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/bj0010028","volume":"1","author":"B Moore","year":"1906","unstructured":"Moore B (1906) On the treatment of diabetus mellitus by acid extract of duodenal mucous membrane. Biochem J 1:28\u201338","journal-title":"Biochem J"},{"key":"18534_CR73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/14656566.2015.1000301","volume":"16","author":"R Morishita","year":"2015","unstructured":"Morishita R, Nakagami H (2015) Teneligliptin: expectations for its pleiotropic action. Expert Opin Pharmacother 16:417\u2013426","journal-title":"Expert Opin Pharmacother"},{"key":"18534_CR74","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","volume":"35","author":"EE Mulvihill","year":"2014","unstructured":"Mulvihill EE, Drucker DJ (2014) Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev 35:992\u20131019","journal-title":"Endocr Rev"},{"key":"18534_CR75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.03.010","volume":"434","author":"M Nabeno","year":"2013","unstructured":"Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, Kadowaki T (2013) A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. Biochem Biophys Res Commun 434:191\u2013196","journal-title":"Biochem Biophys Res Commun"},{"key":"18534_CR76","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2013-2538","volume":"98","author":"M Nannipieri","year":"2013","unstructured":"Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R (2013) Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 98:4391\u20134399","journal-title":"J Clin Endocrinol Metab"},{"key":"18534_CR77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1381\/096089298765554449","volume":"8","author":"E N\u00e4slund","year":"1998","unstructured":"N\u00e4slund E, Backman L, Holst JJ, Theodorsson E, Hellstr\u00f6m PM (1998) Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8:253\u2013260","journal-title":"Obes Surg"},{"issue":"Suppl 2","key":"18534_CR78","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1016\/j.ejim.2009.05.012","volume":"20","author":"MA Nauck","year":"2009","unstructured":"Nauck MA (2009) Unraveling the science of incretin biology. Eur J Intern Med 20(Suppl 2):S303\u2013S308","journal-title":"Eur J Intern Med"},{"key":"18534_CR79","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2010.11.002","volume":"124","author":"MA Nauck","year":"2011","unstructured":"Nauck MA (2011) Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Am J Med 124:S3-18","journal-title":"Am J Med"},{"key":"18534_CR80","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.regpep.2004.07.014","volume":"128","author":"MA Nauck","year":"2005","unstructured":"Nauck MA, Meier JJ (2005) Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept 128:135\u2013148","journal-title":"Regul Pept"},{"key":"18534_CR81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46\u201352","journal-title":"Diabetologia"},{"key":"18534_CR82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","volume":"91","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993a) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Investig 91:301\u2013307","journal-title":"J Clin Investig"},{"key":"18534_CR83","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","volume":"36","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W (1993b) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7\u201336 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:741\u2013744","journal-title":"Diabetologia"},{"key":"18534_CR84","doi-asserted-by":"crossref","unstructured":"Nauck MA, Holst JJ, Willms B (1997): Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 29, 411\u20136","DOI":"10.1055\/s-2007-979067"},{"key":"18534_CR85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/1389201017666160127110125","volume":"17","author":"D Nikolic","year":"2016","unstructured":"Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, Montalto G, Rizvi A, A, Rizzo M, Al-Dughaishi T, (2016) Incretins, pregnancy, and gestational diabetes. Curr Pharm Biotechnol 17:597\u2013602","journal-title":"Curr Pharm Biotechnol"},{"key":"18534_CR86","first-page":"163","volume":"8","author":"S Nishio","year":"2015","unstructured":"Nishio S, Abe M, Ito H (2015) Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability. Diabetes, Metabolic Syndrome and Obesity\u202f: Targets and Therapy 8:163\u2013171","journal-title":"Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy"},{"key":"18534_CR87","doi-asserted-by":"publisher","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","volume":"287","author":"T Nystr\u00f6m","year":"2004","unstructured":"Nystr\u00f6m T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahr\u00e9n B, Sj\u00f6holm \u00c5 (2004) Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 287:E1209\u2013E1215. https:\/\/doi.org\/10.1152\/ajpendo.00237.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"18534_CR88","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.15419\/bmrat.v8i3.663","volume":"8","author":"FO Ohiagu","year":"2021","unstructured":"Ohiagu FO, Chikezie PC, Chikezie CM (2021) Pathophysiology of diabetes mellitus complications: metabolic events and control. Biomedical Research and Therapy 8:4243\u20134257","journal-title":"Biomedical Research and Therapy"},{"key":"18534_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13300-015-0098-y","volume":"6","author":"ES Ommen","year":"2015","unstructured":"Ommen ES, Xu L, O\u2019Neill EA, Goldstein BJ, Kaufman KD, Engel SS (2015) Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials. Diabetes Therapy\u202f: Research, Treatment and Education of Diabetes and Related Disorders 6:29\u201340","journal-title":"Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders"},{"key":"18534_CR90","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/SLA.0b013e3181ae32e3","volume":"250","author":"R Peterli","year":"2009","unstructured":"Peterli R, W\u00f6lnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Fl\u00fce M, Beglinger C (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234\u2013241","journal-title":"Ann Surg"},{"key":"18534_CR91","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1210\/jcem-53-6-1256","volume":"53","author":"MA Pfeifer","year":"1981","unstructured":"Pfeifer MA, Halter JB, Beard JC, Porte D Jr (1981) Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 53:1256\u20131262","journal-title":"J Clin Endocrinol Metab"},{"key":"18534_CR92","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/endo.143.2.8623","volume":"143","author":"V Poitout","year":"2002","unstructured":"Poitout V, Robertson RP (2002) Minireview: secondary beta-cell failure in type 2 diabetes\u2014a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339\u2013342","journal-title":"Endocrinology"},{"key":"18534_CR93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.bmb.a071777","volume":"38","author":"JA Polak","year":"1982","unstructured":"Polak JA, Bloom SR (1982) Localization of regulatory peptides in the gut. Br Med Bull 38:303\u2013307","journal-title":"Br Med Bull"},{"key":"18534_CR94","first-page":"E701","volume":"285","author":"RL Prigeon","year":"2003","unstructured":"Prigeon RL, Quddusi S, Paty B, D\u2019Alessio DA (2003) Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect. American journal of physiology. Endocrinol Metab 285:E701\u2013E707","journal-title":"Endocrinol Metab"},{"key":"18534_CR95","doi-asserted-by":"crossref","unstructured":"Rask E, Olsson T, Soderberg S, Holst Jj J, Tura A, Pacini G, Ahren B (2004): Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism: clinical and experimental 53, 624\u201331","DOI":"10.1016\/j.metabol.2003.11.011"},{"key":"18534_CR96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nsb882","volume":"10","author":"HB Rasmussen","year":"2003","unstructured":"Rasmussen HB, Branner S, Wiberg FC, Wagtmann N (2003) Crystal structure of human dipeptidyl peptidase IV\/CD26 in complex with a substrate analog. Nat Struct Biol 10:19\u201325","journal-title":"Nat Struct Biol"},{"key":"18534_CR97","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.1981.00340130061015","volume":"141","author":"M Rendell","year":"1981","unstructured":"Rendell M, Ross DA, Drew HM, Zarriello J (1981) Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone. Arch Intern Med 141:1617\u20131622","journal-title":"Arch Intern Med"},{"key":"18534_CR98","doi-asserted-by":"crossref","unstructured":"Riz M, Pedersen MG (2015): Mathematical modeling of interacting glucose-sensing mechanisms and electrical activity underlying glucagon-like peptide 1 secretion. PLoS Comput Biol 11, e1004600","DOI":"10.1371\/journal.pcbi.1004600"},{"key":"18534_CR99","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.febslet.2014.08.029","volume":"588","author":"D Rohrborn","year":"2014","unstructured":"Rohrborn D, Eckel J, Sell H (2014) Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Lett 588:3870\u20133877","journal-title":"FEBS Lett"},{"key":"18534_CR100","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2013.06.012","volume":"126","author":"SA Ross","year":"2013","unstructured":"Ross SA (2013) Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes. Am J Med 126:S38-48","journal-title":"Am J Med"},{"key":"18534_CR101","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11096-012-9729-9","volume":"35","author":"S Russell","year":"2013","unstructured":"Russell S (2013) Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction. Int J Clin Pharm 35:159\u2013172","journal-title":"Int J Clin Pharm"},{"key":"18534_CR102","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/13880209.2013.854812","volume":"52","author":"KM Sadek","year":"2014","unstructured":"Sadek KM, Shaheen H (2014) Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats. Pharm Biol 52:591\u2013596","journal-title":"Pharm Biol"},{"key":"18534_CR103","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.biopha.2017.06.023","volume":"92","author":"KM Sadek","year":"2017","unstructured":"Sadek KM, Lebda MA, Nasr SM, Shoukry M (2017) Spirulina platensis prevents hyperglycemia in rats by modulating gluconeogenesis and apoptosis via modification of oxidative stress and MAPK-pathways. Biomed Pharmacother 92:1085\u20131094","journal-title":"Biomed Pharmacother"},{"key":"18534_CR104","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1006\/cyto.1999.0643","volume":"12","author":"FJ Salgado","year":"2000","unstructured":"Salgado FJ, Vela E, Martin M, Franco R, Nogueira M, Cordero OJ (2000) Mechanisms of CD26\/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine 12:1136\u20131141","journal-title":"Cytokine"},{"key":"18534_CR105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","volume":"104","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517\u2013529","journal-title":"Cell"},{"key":"18534_CR106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annepidem.2003.09.016","volume":"14","author":"SH Saydah","year":"2004","unstructured":"Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F (2004) Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol 14:507\u2013516","journal-title":"Ann Epidemiol"},{"key":"18534_CR107","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1463-1326.2010.01212.x","volume":"12","author":"AJ Scheen","year":"2010","unstructured":"Scheen AJ (2010) Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes Obes Metab 12:648\u2013658","journal-title":"Diabetes Obes Metab"},{"key":"18534_CR108","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/dc13-0496","volume":"36","author":"H Sell","year":"2013","unstructured":"Sell H, Bluher M, Kloting N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN, Eckel J (2013) Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36:4083\u20134090","journal-title":"Diabetes Care"},{"key":"18534_CR109","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jdi.12494","volume":"7","author":"M Shimoda","year":"2016","unstructured":"Shimoda M, Kaku K (2016) Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality. Journal of Diabetes Investigation 7:674\u2013676","journal-title":"Journal of Diabetes Investigation"},{"key":"18534_CR110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1573399814666180730105351","volume":"15","author":"EP S\u00f8rgjerd","year":"2019","unstructured":"S\u00f8rgjerd EP (2019) Type 1 diabetes-related autoantibodies in different forms of diabetes. Curr Diabetes Rev 15:199\u2013204","journal-title":"Curr Diabetes Rev"},{"key":"18534_CR111","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","volume":"49","author":"DA Stoffers","year":"2000","unstructured":"Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM (2000) Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741\u2013748","journal-title":"Diabetes"},{"key":"18534_CR112","first-page":"E677","volume":"278","author":"A Suga","year":"2000","unstructured":"Suga A, Hirano T, Kageyama H, Osaka T, Namba Y, Tsuji M, Miura M, Adachi M, Inoue S (2000) Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats. American journal of physiology. Endocrinol Metab 278:E677\u2013E683","journal-title":"Endocrinol Metab"},{"key":"18534_CR113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autneu.2010.09.008","volume":"161","author":"S Trapp","year":"2011","unstructured":"Trapp S, Hisadome K (2011) Glucagon-like peptide 1 and the brain: central actions-central sources? Auton Neurosci 161:14\u201319","journal-title":"Auton Neurosci"},{"key":"18534_CR114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton MD, O\u2019Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69\u201372","journal-title":"Nature"},{"key":"18534_CR115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archinte.1969.00300130043007","volume":"123","author":"RH Unger","year":"1969","unstructured":"Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Intern Med 123:261\u2013266","journal-title":"Arch Intern Med"},{"key":"18534_CR116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-2977(98)00048-5","volume":"52","author":"TF Veneman","year":"1998","unstructured":"Veneman TF, Tack CJ, van Haeften TW (1998) The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe. Neth J Med 52:179\u2013186","journal-title":"Neth J Med"},{"key":"18534_CR117","doi-asserted-by":"crossref","unstructured":"Villanueva-Penacarrillo ML, Marquez L, Gonzalez N, Diaz-Miguel M, Valverde I (2001): Effect of GLP-1 on lipid metabolism in human adipocytes. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 33, 73\u20137","DOI":"10.1055\/s-2001-12428"},{"key":"18534_CR118","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","volume":"50","author":"T Vilsboll","year":"2001","unstructured":"Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ (2001) Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609\u2013613","journal-title":"Diabetes"},{"key":"18534_CR119","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","volume":"45","author":"Q Wang","year":"2002","unstructured":"Wang Q, Brubaker PL (2002) Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice. Diabetologia 45:1263\u20131273","journal-title":"Diabetologia"},{"key":"18534_CR120","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hep.20853","volume":"42","author":"XM Wang","year":"2005","unstructured":"Wang XM, Yu DM, McCaughan GW, Gorrell MD (2005) Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 42:935\u2013945","journal-title":"Hepatology"},{"key":"18534_CR121","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.2741\/2918","volume":"13","author":"XM Wang","year":"2008","unstructured":"Wang XM, Yao TW, Nadvi NA, Osborne B, McCaughan GW, Gorrell MD (2008) Fibroblast activation protein and chronic liver disease. Front Biosci 13:3168\u20133180","journal-title":"Front Biosci"},{"key":"18534_CR122","doi-asserted-by":"crossref","first-page":"43330","DOI":"10.1074\/jbc.M405001200","volume":"279","author":"WA Weihofen","year":"2004","unstructured":"Weihofen WA, Liu J, Reutter W, Saenger W, Fan H (2004) Crystal structure of CD26\/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. J Biol Chem 279:43330\u201343335","journal-title":"J Biol Chem"},{"key":"18534_CR123","doi-asserted-by":"publisher","unstructured":"Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA (1996) Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.\u00a0J Clin Endocrinol Metab 81(1):327\u2013332. https:\/\/doi.org\/10.1210\/jcem.81.1.8550773","DOI":"10.1210\/jcem.81.1.8550773"},{"key":"18534_CR124","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/bi0014498","volume":"40","author":"Q Xiao","year":"2001","unstructured":"Xiao Q, Giguere J, Parisien M, Jeng W, St-Pierre SA, Brubaker PL, Wheeler MB (2001) Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. Biochemistry 40:2860\u20132869","journal-title":"Biochemistry"},{"key":"18534_CR125","doi-asserted-by":"crossref","unstructured":"Yabe D, Seino Y, Seino Y (2017): Incretin concept revised: the origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both? Journal of diabetes investigation","DOI":"10.1111\/jdi.12718"},{"key":"18534_CR126","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-200306000-00012","volume":"21","author":"M Yu","year":"2003","unstructured":"Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M, Roman RJ (2003) Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens 21:1125\u20131135","journal-title":"J Hypertens"},{"key":"18534_CR127","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1742-4658.2006.05253.x","volume":"273","author":"DM Yu","year":"2006","unstructured":"Yu DM, Wang XM, McCaughan GW, Gorrell MD (2006) Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J 273:2447\u20132460","journal-title":"FEBS J"},{"key":"18534_CR128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","volume":"4","author":"B Yusta","year":"2006","unstructured":"Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z, Drucker DJ (2006) GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4:391\u2013406","journal-title":"Cell Metab"},{"key":"18534_CR129","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","volume":"317","author":"T Zhao","year":"2006","unstructured":"Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP (2006) Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther 317:1106\u20131113","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"18534_CR130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2012.09.012","volume":"26","author":"J Zhong","year":"2013","unstructured":"Zhong J, Rao X, Rajagopalan S (2013) An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease. Atherosclerosis 26(2):305\u2013314","journal-title":"Atherosclerosis"},{"key":"18534_CR131","doi-asserted-by":"crossref","unstructured":"Zimmerman RS, Hobbs TM, Wells BJ, Kong SX, Kattan MW, Bouchard J, Chagin KM, Yu C, Sakurada B, Milinovich A, Weng W, Bauman JM, Pantalone KM (2017): Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system. Diabetes, obesity & metabolism","DOI":"10.1111\/dom.12969"},{"key":"18534_CR132","first-page":"20","volume":"31","author":"E Zunz","year":"1929","unstructured":"Zunz E, Labarre J (1929) Contributions a l\u2019etude des variations physiologiques de la secretion interne du pancreas: realations entre les secretions externe et interne du pancreas. Arch Int Physiol Biochim 31:20\u201344","journal-title":"Arch Int Physiol Biochim"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-18534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-022-18534-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-022-18534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T21:31:34Z","timestamp":1700083894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-022-18534-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":132,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["18534"],"URL":"https:\/\/doi.org\/10.1007\/s11356-022-18534-2","relation":{},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review was produced in accordance with the ethics committee of Kafr El-Sheikh University\u2019s Faculty of Veterinary Medicine\u2019s criteria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This review was written by two authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}